###################################################################################################
# trials

# difference between timepoints and times: times helps define markers

default: &default
  is_ows_trial: no
  case_cohort: no

hvtn705: &hvtn705
  two_marker_timepoints: no
  timepoints: [210]
  subset_variable: None
  subset_value: All
  assays: [ELCZ,ELMo,ADCPgp140C97ZAfib,IgG3gp140C97ZAfibritin40delta,IgG3gp140Mos1fibritin40delta,IgG340mdw_gp120,IgG340mdw_gp140,IgG340mdw_V1V2,IgG3gp4140delta,IgG340mdw_multi,IgG340mdw_gp120_gp140_vm,mdw_xassay]
  assay_labels: [IgG to VT-C (EU/ml), IgG to VT-M (EU/ml), Average phagocytosis score to gp140 C97ZA, IgG3 Net MFI to gp140 C97ZA, IgG3 Net MFI to gp140 Mosaic, IgG3 gp120 breadth (Weighted average log10 Net MFI), IgG3 gp140 breadth (Weighted average log10 Net MFI), IgG3 V1V2 breadth (Weighted average log10 Net MFI), IgG3 Net MFI to gp41, IgG3 multi-epitope breadth (Wt average log10 Net MFI), IgG3 gp120 + gp140 breadth (Wt average log10 Net MFI), Overall maximal diversity score]
  primary_assays: [ELCZ,ELMo,ADCPgp140C97ZAfib,IgG3gp140C97ZAfibritin40delta] 
  times: [B, Day210] 
  time_labels: [Day 1, Day 210]
  study_name: HVTN705
  covariates_riskscore: ~.+ RSA + Age + BMI + Riskscore
#  data_cleaned: ../vaccine/p705/correlates_temp/HVTN705_hybridrealmock_practicedata_Oct2021.csv
  data_cleaned: correlates_reporting/data_clean/HVTN705_hybridrealmock_practicedata_Oct2021.csv
  num_boot_replicates: 10
  num_perm_replicates: 10


ows_trial: &ows_trial
  forestplot_script: cor_coxph_forestplots_ows.R
  is_ows_trial: yes
  case_cohort: yes


moderna_trial: &moderna_trial
  <<: *ows_trial
  two_marker_timepoints: yes
  timepoints: [29, 57]
  subset_variable: None
  subset_value: All
  assays: [bindSpike, bindRBD, pseudoneutid50, pseudoneutid80]
  assay_labels: [Binding Antibody to Spike, Binding Antibody to RBD, PsV Neutralization 50% Titer, PsV Neutralization 80% Titer]
  assay_labels_short: [Anti Spike IgG (BAU/ml), Anti RBD IgG (BAU/ml), Pseudovirus-nAb cID50, Pseudovirus-nAb cID80]
  times: [B, Day29, Day57, Delta29overB, Delta57overB, Delta57over29]
  time_labels: [Day 1, Day 29, Day 57, D29 fold-rise over D1, D57 fold-rise over D1, D57 fold-rise over D29]
  data_raw_dir: moderna
  study_name_code: COVE
  covariates_riskscore: ~.+ MinorityInd + HighRiskInd + risk_score
  covariates_norisksco: ~.+ MinorityInd + HighRiskInd + Age

moderna_real: &moderna_real
  <<: *moderna_trial
  data_in_file: immune1.csv 
  data_cleaned: p3001/download_data/Moderna COVE mRNA 1273P301_immune_20210915/moderna_real_data_processed_with_riskscore.csv
  study_name: COVE
  num_boot_replicates: 1000
  num_perm_replicates: 10000

moderna_mock: &moderna_mock
  <<: *moderna_trial
  data_in_file: COVID_VEtrial_practicedata_primarystage1.csv
  study_name: MockCOVE
  num_boot_replicates: 10
  num_perm_replicates: 10


janssen_trial: &janssen_trial
  <<: *ows_trial
  two_marker_timepoints: no
  timepoints: [29]
  assays: [bindSpike, bindRBD]
  assay_labels: [Binding Antibody to Spike, Binding Antibody to RBD]
  assay_labels_short: [Anti Spike IgG (BAU/ml), Anti RBD IgG (BAU/ml)]
  times: [B, Day29, Delta29overB]
  time_labels: [Day 1, Day 29, D29 fold-rise over D1]
  data_raw_dir: janssen
  study_name_code: ENSEMBLE

janssen_trial_real: &janssen_trial_real
  <<: *janssen_trial
  data_in_file: COVID_ENSEMBLE_realdata.csv   #  ../../../mapping_immune_correlates/adata/COVID_ENSEMBLE_realdata.csv
  study_name: ENSEMBLE
  num_boot_replicates: 1000
  num_perm_replicates: 10000

janssen_trial_mock: &janssen_trial_mock
  <<: *janssen_trial
  data_in_file: COVID_ENSEMBLE_practicedata.csv
  study_name: MockENSEMBLE
  num_boot_replicates: 10
  num_perm_replicates: 10

janssen_pooled_real: 
  <<: *janssen_trial_real
  subset_variable: None
  subset_value: All
  covariates_riskscore: ~.+ risk_score + as.factor(Region)
  covariates_norisksco: ~.+ Age        + as.factor(Region)

janssen_na_real: 
  <<: *janssen_trial_real
  subset_variable: Region
  subset_value: 0
  covariates_riskscore: ~.+ risk_score
  covariates_norisksco: ~.+ Age

janssen_la_real: 
  <<: *janssen_trial_real
  subset_variable: Region
  subset_value: 1
  covariates_riskscore: ~.+ risk_score
  covariates_norisksco: ~.+ Age

janssen_sa_real: 
  <<: *janssen_trial_real
  subset_variable: Region
  subset_value: 2
  covariates_riskscore: ~.+ risk_score
  covariates_norisksco: ~.+ Age

janssen_pooled_mock:
  <<: *janssen_trial_mock
  subset_variable: None
  subset_value: All
  covariates_riskscore: ~.+ risk_score + as.factor(Region)
  covariates_norisksco: ~.+ Age        + as.factor(Region)

janssen_na_mock:
  <<: *janssen_trial_mock
  subset_variable: Region
  subset_value: 0
  covariates_riskscore: ~.+ risk_score
  covariates_norisksco: ~.+ Age

janssen_la_mock:
  <<: *janssen_trial_mock
  subset_variable: Region
  subset_value: 1
  covariates_riskscore: ~.+ risk_score
  covariates_norisksco: ~.+ Age

janssen_sa_mock:
  <<: *janssen_trial_mock
  subset_variable: Region
  subset_value: 2
  covariates_riskscore: ~.+ risk_score
  covariates_norisksco: ~.+ Age


###################################################################################################
# correlates analyses

# there are some redundancy in ph1, ph2, WtStratum, wt in that given the first three, we can compute wt
# the redundancy is not needed if we only have single time point analyses
# but for double time points analyses, we need more than one weight variable
# the reason we need WtStratum is that for bootstrapping (needed for some single time point analyses)

# primary endpoint D57 markers
D57:
  ph1: ph1.D57
  ph2: ph2.D57
  wt: wt.D57
  WtStratum: Wstratum
  EventIndPrimary: EventIndPrimaryD57   
  EventTimePrimary: EventTimePrimaryD57   
  tpeak: 57
  tpeaklag: 7
  tfinal.tpeak: 0
  txt.endpoint: COVID
  txt.coxph.note2: No. at-risk = estimated number in the population for analysis, i.e. baseline negative per-protocol vaccine recipients not experiencing the COVID endpoint or infected through 6 days post Day 57 visit; no. cases = number of this cohort with an observed COVID endpoint.

# primary endpoint D29 markers
D29:
  ph1: ph1.D29
  ph2: ph2.D29
  wt: wt.D29
  WtStratum: Wstratum
  EventIndPrimary: EventIndPrimaryD29  
  EventTimePrimary: EventTimePrimaryD29
  tpeak: 29
  tpeaklag: 7
  tfinal.tpeak: 0
  txt.endpoint: COVID
  txt.coxph.note2: No. at-risk = estimated number in the population for analysis, i.e. baseline negative per-protocol vaccine recipients not experiencing the COVID endpoint or infected through 6 days post Day 29 visit; no. cases = number of this cohort with an observed COVID endpoint.

# sensitivity analyses for D29 markers, starting at 1, instead of 7, day after D29 visit
D29start1:
  ph1: ph1.D29start1
  ph2: ph2.D29start1
  wt: wt.D29start1
  WtStratum: Wstratum
  EventIndPrimary: EventIndPrimaryD29  
  EventTimePrimary: EventTimePrimaryD29
  tpeak: 29
  tpeaklag: 1
  tfinal.tpeak: 0
  txt.endpoint: COVID
  txt.coxph.note2: No. at-risk = estimated number in the population for analysis, i.e. baseline negative per-protocol vaccine recipients not experiencing the COVID endpoint or infected through Day 29 visit; no. cases = number of this cohort with an observed COVID endpoint.

D210:
  ph1: Ph1ptids.D210
  ph2: Ph2ptids.D210
  wt: wt.D210
  WtStratum: Sampstratum.D210
  EventIndPrimary: Delta.D210   
  EventTimePrimary: Ttilde.D210
  tpeak: 210
  tpeaklag: 1
  tfinal.tpeak: 0
  txt.endpoint: HIV
  txt.coxph.note2: No. at-risk = estimated number in the population for analysis, i.e. per-protocol vaccine recipients not infected through 1 days post Month 7 visit; no. cases = number of this cohort with an observed endpoint.

  
####################
# two time points 

D29D57:
  tinterm: 29
  tpeak: 57
  tpeaklag: 7
  txt.endpoint: COVID
